Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

May 28, 2020

Primary Completion Date

August 5, 2023

Study Completion Date

August 5, 2023

Conditions
Giant Cell ArteritisLarge Vessel Giant Cell Arteriitis
Interventions
DIAGNOSTIC_TEST

Magnet Resonance Imaging (MRI)

MRI with and without Gadolinium contrast agent for the following vessels: thoracic aorta (ascending, arch, descending arch, left and right common carotic, subclavian, and vertebral artery)

DIAGNOSTIC_TEST

PET/CT analysis

Standard value uptake measurement (SUV) based on quantitative score normalized to liver (SUV vessel max/liver mean) at the following vessel regions: Carotid artery: common, internal, external; Subclavian artery; Axillary artery; Vertebral artery; Thoracic Aorta; Abdominal Aorta; Common femoral artery; Deep femoral artery; Popliteal artery

Trial Locations (1)

4031

Department of Rheumatology, University Hospital Basel, Basel

All Listed Sponsors
collaborator

Swiss Foundation for the Study of Muscular Diseases

UNKNOWN

lead

University Hospital, Basel, Switzerland

OTHER

NCT04204876 - Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course | Biotech Hunter | Biotech Hunter